alcartis 5 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 5 mg
alcartis 10 mg tabletter
egis pharmaceuticals plc - aripiprazol - tabletter - 10 mg
alcartis 15 mg tabletter
egis pharmaceuticals plc - aripiprazol - tabletter - 15 mg
alcartis 30 mg tabletter
egis pharmaceuticals plc - aripiprazol - tabletter - 30 mg
alcartis 5 mg tabletter
egis pharmaceuticals plc - aripiprazol - tabletter - 5 mg
amlodipin "medochemie" 5 mg tabletter
medochemie ltd - amlodipinbesilat - tabletter - 5 mg
amlodipin "taw pharma" 1 mg/ml oral suspension
taw pharma (ireland) ltd - amlodipinbesilat - oral suspension - 1 mg/ml
kesimpta
novartis ireland ltd - ofatumumab - multipel sklerose, recidiverende-remitterende - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
sugammadex "noridem" 100 mg/ml injektionsvæske, opløsning
noridem enterprises ltd. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
firazyr
takeda pharmaceuticals international ag - icatibant - angioødemer, arvelige - hjertetapi - firazyr er indiceret til symptomatisk behandling af akutte angreb af arvelig angioødem (hae) hos voksne (med c1-esterase-hæmmere mangel).